Stock Earnings

Question 1

What are Elicio Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Elicio Therapeutics Inc has a total asset of $28, Net loss of $-52

Question 2

What are the key financial ratios for ELTX?

Accepted Answer

Elicio Therapeutics Inc's Current ratio is 0.71, has a Net margin is 0, sales per share of $0.

Question 3

How is Elicio Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Elicio Therapeutics Inc data is not available.

Question 4

Is Elicio Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Elicio Therapeutics Inc has a net loss of $-52

Question 5

Does Elicio Therapeutics Inc have any liabilities?

Accepted Answer

yes, Elicio Therapeutics Inc has liability of 39

Question 6

How many outstanding shares for Elicio Therapeutics Inc?

Accepted Answer

Elicio Therapeutics Inc has a total outstanding shares of 11.02

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	2	28	2
Revenue Growth (YoY)	--	--	-100%	-93%	1,300%	100%
Cost of Revenue	--	--	--	0	0	1
Gross Profit	--	--	--	2	27	1
Selling, General & Admin	11	11	11	14	18	17
Research & Development	32	--	23	18	48	38
Operating Expenses	44	45	35	32	67	56
Other Non Operating Income (Expenses)	-10	-7	0	0	-13	-16
Pretax Income	-54	-52	-35	-38	-54	-80
Income Tax Expense	0	0	0	--	--	--
Net Income	-54	-52	-35	-38	-54	-80
Net Income Growth	42%	49%	-8%	-30%	-33%	100%
Shares Outstanding (Diluted)	16.05	12	5.05	3	2.82	1.48
Shares Change (YoY)	46%	137%	69%	6%	91%	48%
EPS (Diluted)	-3.4	-4.33	-6.96	-12.92	-19.35	-54.12
EPS Growth	-4%	-38%	-46%	-33%	-64%	33%
Free Cash Flow	-35	-37	-32	-38	-53	-22
Free Cash Flow Per Share	-2.17	-3.08	-6.32	-12.66	-18.79	-14.86
Gross Margin	--	--	--	100%	96.42%	50%
Operating Margin	0%	0%	0%	-1,500%	-139.28%	-2,750%
Profit Margin	0%	0%	0%	-1,900%	-192.85%	-4,000%
Free Cash Flow Margin	0%	0%	0%	-1,900%	-189.28%	-1,100%
EBITDA	-44	-45	-34	-30	-39	-55
EBITDA Margin	0%	0%	0%	-1,500%	-139.28%	-2,750%
D&A For EBITDA	0	0	1	0	0	0
EBIT	-44	-45	-35	-30	-39	-55
EBIT Margin	0%	0%	0%	-1,500%	-139.28%	-2,750%
Effective Tax Rate	0%	0%	0%	--	--	--

Elicio Therapeutics Inc (ELTX) Price